Mutant BCR-ABL clones in chronic myeloid leukemia.

Subjects

Subjects :

Antineoplastic Protocols
Clinical Trials, Phase III as Topic
Clone Cells pathology
Drug Resistance, Neoplasm drug effects
Drug Resistance, Neoplasm genetics
Fusion Proteins, bcr-abl metabolism
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive physiopathology
Mutation
Protein Kinase Inhibitors therapeutic use
Protein-Tyrosine Kinases metabolism
Treatment Failure
Fusion Proteins, bcr-abl genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Protein Kinase Inhibitors administration & dosage
Protein-Tyrosine Kinases genetics

Details

Language :

English

ISSN :

1592-8721

Volume :

96

Issue :

3

Database :

MEDLINE

Journal :

Haematologica

Publication Type :

Editorial & Opinion

Accession number :

21357713

Full Text :

https://doi.org/10.3324/haematol.2010.039560